Published in Fed Proc on January 01, 1974
Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest (1975) 3.24
Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci U S A (1985) 1.75
Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med (1976) 1.56
Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Clin Invest (1977) 1.50
Prostaglandin-like material extracted from squamous carcinomas of the head and neck. Br J Cancer (1980) 1.06
Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer. Proc R Soc Med (1977) 1.06
Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice. J Clin Invest (1986) 0.95
Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects. Am J Pathol (1977) 0.91
Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma. J Clin Invest (1984) 0.84
Bone resorption in organ culture: inhibition by the divalent cation ionophores A23187 and X-537A. J Clin Invest (1976) 0.83
Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma. J Exp Med (1978) 0.80
The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med (1978) 0.78
Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors. Br J Clin Pharmacol (1980) 0.77
Prostaglandins: promulgators of pain. Anesth Prog (1980) 0.75
Differentiated rat glial cell strain in tissue culture. Science (1968) 6.49
Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res (1999) 4.59
Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology (1968) 4.12
Nature and Development of Lactic Dehydrogenases: The two major types of this enzyme form molecular hybrids which change in makeup during development. Science (1962) 3.95
Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A (1976) 3.62
Altered eicosanoid levels in human colon cancer. J Lab Clin Med (1993) 3.32
Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest (1975) 3.24
Specificities of prostaglandins B 1 , F 1 , and F 2 antigen-antibody reactions. J Biol Chem (1971) 3.08
A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc Soc Exp Biol Med (1970) 2.53
Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res (1972) 2.47
Tetanus-toxoid emergency boosters: a reappraisal. N Engl J Med (1969) 2.44
Evidence for selection by male mating success in natural populations of Drosophila pseudoobscura. Proc Natl Acad Sci U S A (1979) 2.38
Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med (1972) 2.36
Corticosteroids inhibit prostaglandin production by rheumatiod synovia. Nature (1975) 2.33
Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats. J Bone Miner Res (1999) 2.05
Thyrotropin-releasing hormone regulates the number of its own receptors in the GH3 strain of pituitary cells in culture. Biochemistry (1975) 2.04
Inositol tetrakis- and pentakisphosphates in GH4 cells. J Exp Biol (1985) 2.02
Recent application of DNA analysis to issues of paternity. J Forensic Sci (1988) 2.01
Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells. Differential effects of hydrocortisone and tissue extracts. J Cell Biol (1970) 2.00
C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med (1973) 1.95
An electrophysiological study of chelonian skeletal muscle. J Physiol (1966) 1.93
Clonal strains of hormone-producing pituitary cells. Methods Enzymol (1979) 1.93
Establishment of four functional, clonal strains of animal cells in culture. Science (1966) 1.90
Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature (1975) 1.82
Ryanodine receptor adaptation and Ca2+(-)induced Ca2+ release-dependent Ca2+ oscillations. Biophys J (1996) 1.78
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest (1980) 1.76
Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc Natl Acad Sci U S A (1985) 1.75
Determination of cyclooxygenase products and prostaglandin metabolites using high-pressure liquid chromatography and radioimmunoassay. Anal Biochem (1979) 1.72
Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5-5 fibroblasts. J Biol Chem (1976) 1.68
Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem (1980) 1.66
Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med (1971) 1.65
Thyrotropin-releasing hormone increases prolactin mRNA activity in the cytoplasm of GH-cells as measured by translation in a wheat germ cell-free system. Biochem Biophys Res Commun (1976) 1.62
Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. Metabolism (1975) 1.60
Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun (1972) 1.60
Prostaglandins in the rheumatic diseases. Ann N Y Acad Sci (1975) 1.58
Detection of medullary thyroid cancer by calcitonin assay in families. Ann Intern Med (1973) 1.56
Prostaglandin synthesis by rheumatoid synovium and its stimulation by colchicine. Prostaglandins (1975) 1.53
Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhbition of cell proliferation. J Cell Biol (1980) 1.52
Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A (1966) 1.47
Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis. Proc Natl Acad Sci U S A (1981) 1.45
The serologic specificity of tropocollagen telopeptides. J Exp Med (1967) 1.45
Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture. Biochem Biophys Res Commun (1971) 1.44
Thyrotropin-releasing hormone-induced spike and plateau in cytosolic free Ca2+ concentrations in pituitary cells. Relation to prolactin release. J Biol Chem (1984) 1.44
Establishment of a clonal strain of hepatoma cells which secrete albumin. J Cell Biol (1969) 1.43
Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. Biochem Biophys Res Commun (1978) 1.41
The serological assessment of a tetanus toxoid field trial. Bull World Health Organ (1971) 1.40
Antibodies to pharmacologically active molecules: specificities and some applications of antiprostaglandins. Pharmacol Rev (1973) 1.40
Can academic radiology departments become more efficient and cost less? Radiology (1998) 1.40
Blood components contribute to rise in gerbil brain levels of leukotriene-like immunoreactivity after ischemia and reperfusion. Stroke (1988) 1.39
Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. N Engl J Med (1968) 1.38
Synthesis of the ninth component of complement by a clonal strain of rat hepatoma cells. J Immunol (1970) 1.38
Epidermal growth factor stimulates prostaglandin biosynthesis by canine kidney (MDCK) cells. Biochem Biophys Res Commun (1977) 1.38
Assay of human thyroid glands for thyrocalcitonin activity. J Clin Endocrinol Metab (1966) 1.37
Human osteopetrosis: a histological, ultrastructural, and biochemical study. J Bone Joint Surg Am (1980) 1.37
The early primary immune response to absorbed tetanus toxoid in man: A study of the influence of antigen concentration, carrier concentration, and sequence of dosage on the rate, extent, and persistence of the immune response to one and to two doses of toxoid. Bull World Health Organ (1973) 1.35
Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor. Nature (1980) 1.35
Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med (1998) 1.35
Receptors for thyrotropin-releasing hormone in prolactin producing rat pituitary cells in culture. J Biol Chem (1973) 1.35
Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts. J Immunol (1966) 1.34
Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension (1981) 1.31
The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis. J Immunol (1965) 1.30
Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. Cancer Res (1965) 1.30
Evidence for the presence of a prostaglandin E 2 -9-keto reductase in rat organs. Biochem Biophys Res Commun (1973) 1.29
Control of growth hormone production by a clonal strain of rat pituitary cells. Stimulation by hydrocortisone. J Cell Biol (1969) 1.28
Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function. J Clin Invest (1971) 1.26
Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. J Clin Invest (1978) 1.26
Release of prostaglandins and metabolites from guinea-pig lung: inhibition by catecholamines. Prostaglandins (1973) 1.26
Antigenic activity of prostaglandins. Biochem Biophys Res Commun (1970) 1.24
Distribution of calcitonin-containing cells in the normal neonatal human thyroid gland: a correlation of morphology with peptide content. J Clin Endocrinol Metab (1975) 1.23
Adjuvant principle of pertussis vaccine in the mouse. Nature (1966) 1.23
Role of prostaglandins in the production of hypercalcemia by tumors. Cancer Res (1978) 1.23
Relationship of thyrotropin-releasing hormone-induced spike and plateau phases in cytosolic free Ca2+ concentrations to hormone secretion. Selective blockade using ionomycin and nifedipine. J Biol Chem (1984) 1.22
Active-passive tetanus immunization. Choice of toxoid, dose of tetanus immune globulin and timing of injections. N Engl J Med (1966) 1.22
Stimulation of prostaglandin biosynthesis by vasoactive substances in methylcholanthrene-transformed mouse BALB/3T3. J Biol Chem (1976) 1.21
Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med (1981) 1.21
Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology (1987) 1.20
Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease. Infect Immun (1984) 1.20